avapritinib
blueprint medicines
['avapritinib']
live from #ash22: a new study has found that 200 mg of avapritinib once a day is effective and well tolerated among treatment-na ve patients with advanced systemic mastocytosis. read more about the study here: #systemicmastocytosis #raredisease 
Rare Disease Advisor's SM Junction offers clinicians who treat systemic mastocytosis daily news, insights, and resources about treating the disease.